NASHVILLE, Tenn., Sept. 30, 2025 (GLOBE NEWSWIRE) -- 360 Privacy today announced the launch of 360 Strata, an advanced privacy platform designed to transform how ...
The FDA approved Guardant 360 CDx for identifying ESR1 mutations in advanced breast cancer patients eligible for imlunestrant treatment. Imlunestrant showed a 38% reduction in disease progression risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback